Targeting the Receptor for Advanced Glycation End-Product (RAGE): An ADC Perspective

Time: 12:00 pm
day: Track B - Day 2

Details:

  •  Examining the preclinical development of RAGE-ADC versions
  • Focusing on female cancers
  • Updates on Swansea University’s ADC Clinical pipeline and development platforms

Speakers: